Steris Plc (ireland) · NYSE:STE
Steris Plc (ireland) — STERIS — SG Cowen Healthcare Conference 2005
15 slides from Steris Plc (ireland)'s conference presentation, Mar 16, 2005
Slide 1: Counting on STERIS
Counting on STERIS SG Cowen Healthcare Conference Boston, MA March 16, 2005
Slide 2: Forward-Looking Statements
Forward-Looking Statements Except for historical information discussed, today’s presentation includes forward-looking statements that involve risks and uncertainties. Investors are cautioned that such statements are only predictions and that actual events or results may differ materially. Some of th
Slide 3: Overview
Overview
Slide 4: Reasons to Consider STERIS
Reasons to Consider STERIS 1. We are a market leader 2. Strong underlying industry demand 3. Stable company with strong financial position Solid cash generation Low debt levels Consistently high gross margins 4. Substantial opportunities for growth in new markets and geographies 5. Consistent revenu
Slide 5: Our Evolution
Our Evolution INITIAL GROWTH ACQUISITIONS REORGANIZATION 1987 Start up STERIS 1995 STERIS 2000 STERIS Today Leader in Technologies to Control Infection and Contamination $1 billion Positioned For Growth
Slide 6: High Arching Vision
High Arching Vision AT STERIS WE HAVE A VISION To See The World Free From Infection And Contamination
Slide 7: Only Company Like This
Only 1 Company Like This We have a unique product offering Capital Equipment Consumables Service This balanced revenue stream allows us: A stronger competitive position Protection from capital spending cycles Higher margins from consumables and service The ability to offer customers a total solution
Slide 8: Where you will find STERIS
Where you will find STERIS Healthcare (Hospitals and Surgical Centers) OR and Critical Care Sterile Processing of Surgical Instruments Caregiver Skin Care Products Life Sciences (Pharma Production & Research, Defense) Pharmaceutical Production Facilities Research Labs Defense and Industrial STERIS I
Slide 9: Strategic Direction
Strategic Direction
Slide 10: Key Growth Drivers
Key Growth Drivers Sustainable Profitable Growth Market Growth Improve Execution 3 drivers Diversify Revenue
Slide 11: Key Market Growth Drivers
Key Market Growth Drivers Healthcare: Organic growth of 5-7% Drivers = aging population, surgical procedure growth, hospital spending on construction, concerns over hospital acquired infections Life Sciences: Organic growth of 8-10% Drivers = aging population, drug consumption, ongoing investment in
Slide 12: Actions to Improve Execution
Actions to Improve Execution We have a focused initiative underway that will change the culture and the way we do business by transforming our: Business Processes Becoming a market-led organization Focusing on lean operations Management Processes Improving planning, talent and performance management
Slide 13: Our Growth Strategy
Our Growth Strategy Diversify revenue stream by product, service, market and geography 1. Increase recurring revenues 2. Leverage our channel 3. Introduce new technologies 4. Adapt our technologies 5. Expand internationally 2.8 million cubic ft. decontaminated
Slide 14: Recent Strategic Actions
Recent Strategic Actions Acquisition of Albert Browne Limited—September 2004 Offers biological and chemical indicators (consumables) Products are used with capital equipment Acquisition of Cosmed Group, Inc.—January 2005 Contract sterilization (services) Strengthens STERIS’s EtO position Life Scienc
Slide 15: Why own STERIS?
Why own STERIS? 1. Market leader 2. Growing markets 3. Strong financial position 4. Substantial opportunities 5. Consistent revenue stream 5 reasons to invest